Prognostic Impact of Low Muscle Mass and Inflammatory Markers in Stage III Nonsmall Cell Lung Cancer Turkish Oncology Group and Turkish Society of Radiation Oncology Thoracic Cancer Study Group (08-005).

Gumustepe E., Yavas G., Kirakli E. K., Dincbas F. Ö., N D., Hurmuz P., ...Daha Fazla

American journal of clinical oncology, sa.00, 2024 (SCI-Expanded) identifier